A randomized, placebo-controlled pilot study in huntington's disease [HD] (CIT-HD).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Citalopram (Primary)
- Indications Huntington's disease
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Acronyms CIT-HD
- 13 Mar 2013 Biomarkers information updated
- 29 May 2012 Actual patient number changed from 28 to 33 as reported by ClinicalTrials.gov.
- 18 May 2012 Actual patient number 28 added as reported by ClinicalTrials.gov.